13D/13G Filings - Venrock Associates VII L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
4:12 pm
Unchanged
2021-12-31 13G Unity Biotechnology, Inc.
UBX
Venrock Associates VII L.P. 268,004
4.600%
0
(Unchanged)
Filing
History
2022-02-14
4:11 pm
Purchase
2021-12-31 13G CYTEIR THERAPEUTICS INC
CYTT
Venrock Associates VII L.P. 3,259,022
9.200%
3,259,022increase
(New Position)
Filing
History